Skip to main content
Explore URMC

Golisano Children's Hospital Logo

menu

Publications

2017

2016

2015

  • Chow EJ, Asselin BL, Schwartz CL, et al. (2015). Late mortality after Dexrazoxane treatment: a report from the Children's Oncology Group. Journal Clinical Oncology. Aug 20;33(24):2639-45. doi: 10.1200/JCO.2014.59.4473.
  • Asselin BL, Rizzari C. (2015). Asparaginase pharmacokinetics and implications of therapeutic drug monitoring. Leuk Lymphoma. 2015;56(8):2273-80. doi: 10.3109/10428194.2014.1003056. Epub 2015 Mar 11.
  • Biondi EA, Gottfried JA, Dutko Fioravanti I, Schriefer JA, Aligne CA, Leonard MS. (2015). Interobserver reliability of attending physicians and bedside nurses when using an inpatient paediatric respiratory score. Journal of Clinical Nursing. 24(9-10):1320-6.
  • Biondi EA, Varade WS, Garfunkel LC, Lynn JF, et al. (2015). Discordance between residents and faculty perceptions of resident autonomy: can self-determination theory help interpret differences and guide strategies for bridging the divide? Academic Medicine: Journal of the Association of American Medical Colleges. 90(4):462-71.
  • Bleyer A, Asselin BL, Koontz SE, et al. (2015). Clinical application of asparaginase activity levels following treatment with pegaspargase. Pediatric Blood and Cancer. 62(6): 1102-5.
  • Chow E, Asselin BL, Schwartz C, et al. (2015). Late mortality after dexrazoxane treatment: a report from the Children’s Oncology Group. Journal of Clinical Oncology. May 26.
  • Houliares D, Taylor-Brown, S, Werth K, Benotti L, Schriefer JA, et al. (2015). Using quality improvement methods to enhance volunteer experiences at EquiCenter. Strides – Journal for the Professional Association of Therapeutic Horsemanship (Path Inc.). Winter: 41-45.
  • McCulloh R, Koster M, Yin DE, Milner T, Ralston S, Hill VL, Alverson BK, Biondi EA. (2015). Evaluating the use of blood cultures in the management of children hospitalized for community-acquired pneumonia. PLoS One. 6:10(2):e0117462.
  • Mischler M, Ryan MS, Leyenaar JK, Markowsky A, Seppa M, Wood K, Ren J, Asche C, Gigliotti F, Biondi EA. (2015). Epidemiology of bacteremia in previously health febrile infants: a follow-up study. Hospital of Pediatrics. 5(6):293-300.
  • Moler FW, Silverstein FS, Holubkov R, Slomine BS, Christensen JR, Nadkarni VM, Meert KL, Clark AE, van der Jagt EW, Porter MB. (2015). Therapeutic hypothermia after out-of-hospital cardiac arrest in children. New England Journal of Medicine. 372(2): 1898-1908. Epub. April 25.
  • Sauers-Ford HS, Simmons JM, Shah SS and the H2O Study Team (*Solan LG). Strategies to Engage Stakeholders in Research to Improve Acute Care Delivery. J Hosp Med, Epub September 2015 (doi: 10.1002/jhm.2492) (*Collaborator)
  • Solan LG, Beck AF, Brunswick SA, Sauers HS, Wade-Murphy S, Simmons JM, Shah SS, Sherman SN on behalf of the H2O Study Group. The Family Perspective on Hospital to Home Transitions: A Qualitative Study, Pediatrics Dec 2015, 136 (6) e1539-e1549; DOI: 10.1542/peds.2015-2098
  • Schriefer JA. (2015). Christiansen J, Atkinson SA. A great idea: staff satisfaction survey. Strides – Journal for the Professional Association of Therapeutic Horsemanship (Path Inc.). Summer: 46-48.
  • Schroeder AR, Shen M, Biondi EA, et al. (2015). Bacteremic urinary tract infection: management and outcomes in young infants. Archives of Disease in Childhood. Epub. July 15.
  • Schroeder AR, Chang PW, Shen MW, Biondi EA, et al. (2015). Diagnostic accuracy of the urinalysis for urinary tract infection in infants 3 months of age. Pediatrics. 135(6):965-71.
  • Winter SS, Dunsmore KP, Devida M, Eisenberg N, Asselin BL, et al. (2015). Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children’s Oncology Group Study AALL0434. Pediatric Blood Cancer. 62:1176-1183.

2014

  • Asselin BL, Fisher V. (2014). Impact of clinical and subclinical hypersensitivity to asparaginase in acute lymphoblastic leukemia. [Epub ahead of print] doi: 10.1188/14.CJON. Clinical Journal of Oncology Nursing. 2014. 18(6): E102-12.
  • Biondi EA, Leonard MS, Nocera E., et al. (2014). Tempering pediatric hospitalist supervision of residents improves admission process efficiency without decreasing quality of care. Journal of Hospital Medicine: an official publication of the Society of Hospital Medicine. 9(2):106-10.
  • Biondi EA. (2014). It doesn't have to be EviDense. Hospital Pediatrics. 4(1):48-50, 4(2):113-5, 4(3):188-9, 4(4):259-60.
  • Biondi EA, McCulloh R, Alverson B, Klein A, Dixon A, Ralston S. (2014). Treatment of mycoplasma pneumonia: A systematic review. Pediatrics. 133(6):1081-90.
  • Biondi EA, Mischler M, Jerardi KE, et al. (2014). Blood culture time to positivity in febrile infants with bacteremia. JAMA Pediatrics. 168(9):844-9.
  • Biondi EA, Varade WS, Garfunkel LC, Lynn JF, et al. (2014). Discordance between resident and faculty perceptions of resident autonomy: can self-determination theory help interpret differences and guide strategies for bridging the divide? Academic Medicine: Journal of the Association of American Medical Colleges. Epub October 21.
  • Biondi EA. (2014). The superbugs are coming! Hospital Pediatrics. 4(6):408-410.
  • Lowenstein LM, Brown K, Barrows D, Foti T, Scholer L, LeVant C, Schriefer JA. (2014). Continuous quality improvement in a level IIIB NICU to increase human milk use at day of life 14, day of life 28, and discharge. ICAN: Infant, Child, & Adolescent Nutrition. 6(3): 137-143.
  • Meyer JS, Riese J, Biondi EA. (2014). Is dexamethasone an effective alternative to oral prednisone in the treatment of pediatric asthma exacerbations? Hospital Pediatrics. 4(3):172- 80.
  • Salzer WL, Asselin BL, Plourde PV, et al. (2014). Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia. Academic Science. 1329(2014): 81-92.
  • Tower RL, Jones TL, Camitta BM, Asselin BL, et al. (2014). Dose intensification of intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: A report from the Children's Oncology Group. Journal of Pediatric Hematology/Oncology. 36(5): 353-61.